What is it about?

Vegard Tuseth founded Nuheart AS in 2014 to develop a ventricular assist device (VAD), for patients with severe heart failure. He talks about his move from a senior clinical position in a large teaching hospital to setting up the company based in Bergen, Norway single-handedly.

Featured Image

Why is it important?

The implantable VAD is designed to treat patients with severe heart failure without the need for surgery. The catheter-based delivery and placement system draws on the latest methods and technologies to provide high levels of efficiency and stability.


Vegard Tuseth's decision to step down from his post as head of interventional cardiology at Haukeland University Hospital in Bergen, Norway was an unusual one. Leaving the security of academia to develop a new ventricular assist device was fraught with risk, but his conviction has paid off. His journey from setting up the company to becoming its chairman in the space of two short years is remarkable and inspiring.

Judith Ozkan

Read the Original

This page is a summary of: Vegard Tuseth MD PhD from academia to industry, European Heart Journal, January 2017, Oxford University Press (OUP),
DOI: 10.1093/eurheartj/ehw667.
You can read the full text:




The following have contributed to this page